During the past decade, The Children's Hospital at TriStar Centennial Medical Center/ Sarah Cannon Center for Blood Cancers conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Children's Hospital at TriStar Centennial Medical Center/ Sarah Cannon Center for Blood Cancers" #1 sponsor was "Vertex Pharmaceuticals Incorporated" with 4 trials, followed by "Celgene" with 2 trials sponsored, "Alpine Immune Sciences, Inc." with 1 trials sponsored, "Juno Therapeutics, a Subsidiary of Celgene" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Children's Hospital at TriStar Centennial Medical Center/ Sarah Cannon Center for Blood Cancers" #1 collaborator was "CRISPR Therapeutics" with 4 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "The Children's Hospital at TriStar Centennial Medical Center/ Sarah Cannon Center for Blood Cancers" are "Hemoglobinopathies" (4 trials), "Multiple Myeloma" (3 trials), "Sickle Cell Disease" (3 trials), "Beta-Thalassemia" (2 trials) and "Genetic Diseases, Inborn" (2 trials). Many other conditions were trialed in "The Children's Hospital at TriStar Centennial Medical Center/ Sarah Cannon Center for Blood Cancers" in a lesser frequency.

Most popular intervention types in "The Children's Hospital at TriStar Centennial Medical Center/ Sarah Cannon Center for Blood Cancers" are "Biological" (7 trials) and "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "CTX001" (4 trials), "Cyclophosphamide" (2 trials), "Fludarabine" (2 trials), "ALPN-101" (1 trials) and "Antibody Drug Conjugate Chemotherapeutic" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Children's Hospital at TriStar Centennial Medical Center/ Sarah Cannon Center for Blood Cancers" are 9 trials for "All" genders.

Currently, there are NaN active trials in "The Children's Hospital at TriStar Centennial Medical Center/ Sarah Cannon Center for Blood Cancers". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in The Children's Hospital at TriStar Centennial Medical Center/ Sarah Cannon Center for Blood Cancers, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Children's Hospital at TriStar Centennial Medical Center/ Sarah Cannon Center for Blood Cancers, 4 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".